French-based pre-clinical services provider CiToxLAB Group has announced that it has acquired a pre-clinical contract research company known as AccelLAB.
The target company is based in Canada and employs approximately 100 people.
Go deeper with GlobalData
The acquisition is expected to foster the acquirer’s position in non-clinical contract research and will also help it provide services to the medical devices sector.
Sichuan Kelun Pharma, a company based in China, plans to acquire full ownership in a biopharmaceutical company based in Guangxi, in which it already holds 80%, by acquiring the remaining 20% stake.
In another acquisition, the same company plans to acquire a 35% stake in a biopharmaceutical company based in Changshu. The value of the acquisition is estimated to be ¥36m ($5.3m).
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
